olprinone has been researched along with Thrombopenia in 1 studies
olprinone: RN refers to HCl; structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "Our results demonstrate possible contribution of the enhancing effects of acetylamrinone on platelet aggregation occurring under blood flow conditions, which reduced the platelet count when occurring in real circulation, to the higher incidence of thrombocytopenia in patients treated with amrinone." | 7.72 | Possible contribution of acetylamrinone and its enhancing effects on platelet aggregation under shear stress conditions in the onset of thrombocytopenia in patients treated with amrinone. ( Goto, S; Handa, S; Hoshiba, Y; Ikeda, Y; Kumagai, A; Sadiq, A; Tamura, N; Tanabe, T; Yoshida, M, 2003) |
| "Our results demonstrate possible contribution of the enhancing effects of acetylamrinone on platelet aggregation occurring under blood flow conditions, which reduced the platelet count when occurring in real circulation, to the higher incidence of thrombocytopenia in patients treated with amrinone." | 3.72 | Possible contribution of acetylamrinone and its enhancing effects on platelet aggregation under shear stress conditions in the onset of thrombocytopenia in patients treated with amrinone. ( Goto, S; Handa, S; Hoshiba, Y; Ikeda, Y; Kumagai, A; Sadiq, A; Tamura, N; Tanabe, T; Yoshida, M, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sadiq, A | 1 |
| Tamura, N | 1 |
| Yoshida, M | 1 |
| Hoshiba, Y | 1 |
| Kumagai, A | 1 |
| Tanabe, T | 1 |
| Handa, S | 1 |
| Ikeda, Y | 1 |
| Goto, S | 1 |
1 other study available for olprinone and Thrombopenia
| Article | Year |
|---|---|
Possible contribution of acetylamrinone and its enhancing effects on platelet aggregation under shear stress conditions in the onset of thrombocytopenia in patients treated with amrinone.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adult; Amrinone; Cyclic Nucleotide Phosphodiesterases, Type 3; | 2003 |